Study of Xience Skypoint stents in everyday heart care
Part of Heart & circulation clinical trials.
This trial is checking how well Xience Skypoint stents work and how safe they are for people who need them to open blocked heart arteries. It's for patients getting these stents as part of their normal treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older
- You are scheduled to receive a Xience Skypoint stent during your procedure
- You or your guardian agrees to the study plan and signs a consent form
- You are not getting any other type of drug-coated stent at the same time
- You do not have a terminal illness that makes your life expectancy less than 1 year
- You are not in cardiogenic shock (a severe state where the heart can't pump enough blood)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how safe and effective two types of heart stents (Synergy XD and Synergy Megatron) are after they are placed. You might consider it if you’re an adult getting one of these stents and can follow required clinic visits.
This study follows people who need a heart procedure to open narrowed coronary arteries using a drug-coated stent. It aims to see how well these stents work and how people do in everyday clinical practice.
This trial looks at how safe and effective two specific stents are when doctors use them as part of routine care. You may be a candidate if you’re an adult receiving one of these Ultimaster stents and can follow the study check-in schedule.
This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.
This trial looks at how different types of drug-coated stents work in everyday care for people with blocked heart arteries. It may help doctors choose the best stent type to keep the artery open after treatment.
This trial compares two types of drug-coated stents (one with sirolimus, one with everolimus) in people who have had a heart attack or unstable angina and need a stent. It aims to see which stent works better for new blockages in the heart arteries.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.